Arsanis, Inc. (ASNS): Price and Financial Metrics


Arsanis, Inc. (ASNS): $3.11

-0.13 (-3.86%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ASNS Stock Price Chart Interactive Chart >

Price chart for ASNS

ASNS Price/Volume Stats

Current price $3.11 52-week high $28.69
Prev. close $3.23 52-week low $1.15
Day low $3.05 Volume 607,200
Day high $3.78 Avg. volume 164,537
50-day MA $2.99 Dividend yield N/A
200-day MA $4.17 Market Cap 45.54M

Arsanis, Inc. (ASNS) Company Bio


Arsanis, Inc., a clinical-stage biopharmaceutical company, focuses on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases. Its lead product candidate is ASN100, a first-in-class mAb therapeutic in Phase II clinical development for the prevention of staphylococcus aureus pneumonia. The company’s preclinical pipeline comprises mAbs targeting multiple serious bacterial and viral pathogens, including respiratory syncytial virus. Arsanis, Inc. was founded in 2010 and is based in Waltham, Massachusetts.


ASNS Latest News Stream


Event/Time News Detail
Loading, please wait...

ASNS Latest Social Stream


Loading social stream, please wait...

View Full ASNS Social Stream

ASNS Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 1.1437 seconds.